Comparison of Effectiveness Among Different Sodium-Glucose Cotransoporter-2 Inhibitors According to Underlying Conditions: A Network Meta-Analysis of Randomized Controlled Trials

By sjmartinez • February 1, 2024

Kani R, Watanabe A, Miyamoto Y, Ejiri K, Iwagami M, Takagi H, Slipczuk L, Tsugawa Y, Aikawa T, Kuno T. Comparison of Effectiveness Among Different Sodium-Glucose Cotransoporter-2 Inhibitors According to Underlying Conditions: A Network Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2024 Jan 31:e031805. doi: 10.1161/JAHA.123.031805. Epub ahead of print. PMID: 38293914.

Tags: cardiovascular death or hospitalizations for HF, CKD, diabetes, General Internal Medicine, network meta‐analysis, Publications, SGLT2 inhibitors

A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study

Debonnaire P, Zwetsloot PP, Pfister R, Llàcer P, Cipriani A, Milani P, Bonderman D, Ohlmeier C, Evers T, Wyss R, Patorno E, Doshi R, Beisel[...]

Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma

Paniker AG, Marshalek JP, Chao E, Yashar D, Tomassetti S. Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma. J Hematol. 2026 Aug 31;15(4):188-197.[...]

Primary care physician characteristics and potentially inappropriate medications in older adults

Tatsuno Y, Sarkisian CA, Mafi JN, Kitajima K, Sato D, Tsugawa Y, Miyawaki A. Primary care physician characteristics and potentially inappropriate medications in older adults.[...]